tirzepatide approved for osa The FDA has expanded the approval of Eli Lilly's obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea people with obesity — the first medication for the The FDA approved Zepbound (tirzepatide)
Pay in 4 interest-free payments of $7.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29


:max_bytes(150000):strip_icc()/GettyImages-2126120280-94c8334d07474c6883f6bb568b95693f.jpg)























